Erbitux 100mg/1Vial Injection (Cetuximab) | LoveShop.pk

The Erbitux 100mg Injection (Active Ingredient Cetuximab) Is Primarily Used To Treat Specific Types Of Cancer, Including Metastatic Colorectal Cancer (Cancer Of The Colon And Rectum That Has Spread To Other Parts Of The Body). It Works By Targeting The Epidermal Growth Factor Receptor (Egfr) On Cancer Cells, Blocking Signals That Promote Their Growth And Survival, Thus Preventing Cancer Cell Proliferation. Squamous Cell Carcinoma Of The Head And Neck, Including Cancers Of The Mouth, Nose, Sinuses, Or Throat. It Is Used In Various Settings Such As: In Combination With Radiation Therapy For Locally Advanced Disease.  With Platinum-based Chemotherapy And Fluorouracil For Recurrent Or Metastatic Disease.  As A Single Agent For Disease That Has Progressed After Platinum-based Therapy.

How Does Erbitux 100mg Injection Work?

Erbitux Works By Targeting And Binding To A Protein Called Epidermal Growth Factor Receptor (Egfr), Which Is Present On The Surface Of Many Cancer Cells.

Here’s How It Works

Binding To Egfr: Erbitux Binds To Egfr, Blocking The Activation Of This Receptor By Natural Growth Factors Such As Epidermal Growth Factor (Egf). Egfr Plays A Crucial Role In Cell Growth And Division. In Many Cancer Cells, Egfr Is Overexpressed, Leading To Uncontrolled Cell Proliferation. Inhibiting Signal Transduction: By Blocking Egfr, Erbitux Prevents The Transmission Of Signals That Would Normally Encourage Cancer Cells To Grow And Divide. This Inhibition Slows Down Or Stops The Growth Of The Tumor. Inducing Immune Response: Erbitux Also Activates The Immune System By Promoting An Immune Response That Targets And Destroys Cancer Cells. This Occurs Through Mechanisms Like Antibody-dependent Cellular Cytotoxicity (Adcc), Where Immune Cells Are Recruited To Kill The Tumor Cells. Effects On Cancer Cells: As A Result Of These Actions, The Growth Of The Cancer Cells Is Slowed Down, And It May Help Shrink Existing Tumors, Improving The Overall Progression Of The Disease.

How Should You Take Erbitux 100mg Injection?

Erbitux (Cetuximab) 100mg Injection Is Typically Administered By A Healthcare Professional In A Hospital Or Clinic Setting. It Is Given Through An Intravenous (Iv) Infusion Into A Vein. Before You Receive The Injection, Your Doctor Will Determine The Appropriate Dosage And How Often You Should Receive The Treatment Based On Your Condition, Medical History, And Response To Previous Treatments. The Infusion Is Usually Started Slowly To Monitor For Any Allergic Reactions Or Side Effects, With The Rate Increasing Over Time. Depending On The Condition Being Treated (Such As Head And Neck Cancer Or Colorectal Cancer), You May Receive Erbitux Weekly Or Every Two Weeks. It’s Important That You Follow Your Doctor’s Instructions And Attend All Scheduled Appointments For Treatment. If You Experience Any Severe Reactions During Or After The Infusion, Such As Difficulty Breathing, Skin Rash, Or Fever, Notify Your Healthcare Provider Immediately. Always Consult Your Doctor For Personalized Advice And Guidance On Taking Erbitux, As They Will Tailor Your Treatment Plan To Your Specific Needs.